Our team is expanding, as is our clinical focus. We currently have 4 Clinical Pharmacists providing care to 14 sites across the State. Another 2 pharmacists are joining the team this fall. In addition, we presented outcomes from one of our first participating practices at the American Society of Clinical Oncology (ASCO) Quality Symposium in September 2021. In this abstract, the POEM pharmacist’s role in Oral Anticancer Agent (OAA) management resulted in a significant decrease in time to patient follow-up after starting OAA therapy. Clinical areas our team is currently focusing on are OAA management, immuno-oncology management, and management of gastrointestinal toxicities from chemotherapy. All POEM pharmacists have been heavily involved in providing patient education at their sites. We’re enrolling additional oncology practices for participation. Please see www.moqc.org/poem or contact Emily Mackler, PharmD, BCOP, Director, POEM at emackler@moqc.org if you’re interested in participating or learning more. Participation in the program includes support in hiring the pharmacist and in the opportunity to receive value-based reimbursement.